The main purpose of this study is to see whether Axitinib will help prolong the time that the
patient's carcinoid tumors remain stable, and to examine their treatment response through
testing. Researchers also want to find out if Axitinib is safe and tolerable.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute